A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Moc-Leu-OH | Moc-Leu-OH. Synonyms: MeOCO-Leu-OH; Moc Leu OH; N-Carbomethoxy-L-leucine. CAS No. 74761-37-8. Molecular formula: C8H15NO4. Mole weight: 189.21. |  |
| Moclobemide | Moclobemide (Ro111163) is a brain-penetrant and reversible monoamine oxidase ( MAO-A ) inhibitor with an IC 50 of 6.061 μM for hMAO-A [1].Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Ro111163. CAS No. 71320-77-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0534. |  |
| Moclobemide | Moclobemide. Group: Biochemicals. Grades: Purified. CAS No. 71320-77-9. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| Moclobemide | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C13H17ClN2O2. CAS No. 71320-77-9. Prepack ID 68942587-1g. Molecular Weight 268.74. See USA prepack pricing. |  |
| Moclobemide N-Oxide | Moclobemide N-Oxide is a metabolite of Moclobemide (M481000), a reversible monoamine oxidase inhibitor. Group: Biochemicals. Grades: Highly Purified. CAS No. 64544-24-7. Pack Sizes: 10mg, 100mg. Molecular Formula: C13H17ClN2O3. US Biological Life Sciences. | Worldwide |
| Moclobemide (Ro-11-1163, Aurorix, Manerix, Moclamine, p-Chloro-N- (2-morpholinoethyl) benzamide) | A reversible monoamine oxidase inhibitor. Group: Biochemicals. Alternative Names: Ro-11-1163, Aurorix, Manerix, Moclamine, p-Chloro-N- (2-morpholinoethyl) benzamide. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| MOC-L-Tert-Leucine | MOC-L-Tert-Leucine is used as a pharmaceutical intermediate for the synthesis of drugs such as Atazanavir. CAS No. 162537-11-3. Product ID: PAP-0021. Molecular formula: C8H15NO4. Category: Amino acid. Product Keywords: Amino Acid Series; MOC-L-Tert-Leucine; PAP-0021; Amino acid; C8H15NO4; 162537-11-3. EC Number: 431-620-3. Physical State: powder. Solubility: Soluble in ethyl acetate and methanol. Storage: 2-8°C. Boiling Point: 320.9±25.0 °C(Predicted). Melting Point: 109°C. Density: 1.126±0.06 g/cm3(Predicted). |  |
| MOC-L-Valine | MOC-L-valine (S)-2-((methoxycarbonyl) amino)-3-methylbutyric acid, a key synthetic intermediate of ledipasvir, is indicated for the treatment of chronic hepatitis C Virus (HCV) infection in adults and adolescents aged 12 to <18 years. CAS No. 74761-42-5. Product ID: PAP-0015. Molecular formula: C7H13NO4. Category: Amino acid. Product Keywords: Amino Acid Series; MOC-L-Valine; PAP-0015; Amino acid; C7H13NO4; 74761-42-5. Color: White to Almost white. Physical State: powder to crystal. Storage: Sealed in dry,Room Temperature. Applications: Moc-l-valine, also known as (S)-2-((methoxycarbonyl) amino) -3-methylbutyric acid, is a key synthetic intermediate for the treatment of chronic hepatitis C virus (HCV) infection in adults and adolescents aged 12 to <18 years. Boiling Point: 315.9±25.0 °C(Predicted). Melting Point: 109.0 to 113.0 °C. Density: 1.154±0.06 g/cm3(Predicted). Product Description: Moc-l-valine, also known as (S)-2-((methoxycarbonyl) amino) -3-methylbutyric acid, is a key synthetic intermediate for the treatment of chronic hepatitis C virus (HCV) infection in adults and adolescents aged 12 to <18 years. | |
| MOCPAC | ?95% (HPLC), solid. Group: Fluorescence/luminescence spectroscopy. |  |
| MOC-POC Tenofovir Fumarate Salt (Mixture of Diastereomers) | MOC-POC Tenofovir Fumarate Salt (Mixture of Diastereomers). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 5-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic Acid (1-Methylethyl,methyl) Ester 5-Oxide Fumarate, MOC-POC PMPA Fumarate. IUPAC Name: [[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(methoxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid. Molecular formula: C17H26N5O10P.C4H4O4. Mole weight: 607.46. Catalog: APS002361. SMILES: COC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C.OC(=O)\C=C\C(=O)O. Format: Neat. | |
| MOC-POC Tenofovir Fumarate Salt (Mixture of Diastereomers) | Tenofovir impurity. Group: Biochemicals. Alternative Names: 5-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Moc-Pro-OH | Moc-Pro-OH. Synonyms: MeOCO-Pro-OH; Moc Pro OH; 1-(methoxycarbonyl)-L-proline; N-Carbomethoxy proline. CAS No. 74761-41-4. Molecular formula: C7H11NO4. Mole weight: 173.17. | |
| Mocravimod hydrochloride | Mocravimod hydrochloride (KRP-203), an immunosuppressant, is a potent and orally active S1PR1 (sphingosine 1-phosphate receptor type 1) agonist [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: KRP-203. CAS No. 509088-69-1. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-13660. | |
| Moc-Val-Val-OH | Moc-Val-Val-OH. Synonyms: Moc Val Val OH. Molecular formula: C12H22N2O5. Mole weight: 274.31. | |
| Modafinil Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Modafinil Related Compound D | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Modafinil Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Modakafusp alfa | Modakafusp alfa (TAK-573) is a humanized, anti-CD38 IgG4 monoclonal antibody fused to 2 attenuated IFNα2b molecules, which delivers interferon-alpha to CD38 -expressing cells. Modakafusp alfa has direct anti-proliferative activity on multiple myeloma (MM) cancer cells in vitro and induces robust and durable antitumor responses in MM xenograft tumor models. Modakafusp alfa in combination with anti-PD-1 antibodies induces immunomodulation and antitumor responses with good tolerance in mice [1] [2] [3] [4]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: TAK-573. CAS No. 2254522-19-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99744. | |
| Modecainide | Modecainide. Group: Biochemicals. Alternative Names: 4-hydroxy-3-methoxy-N- [2- [2- (1-methyl-2-piperidinyl) ethyl] phenyl] benzamide; 3-Methoxy-O-demethyl Encainide; 3-Methoxy-O-desmethylencainide; BMY 40327; MJ 14030. Grades: Highly Purified. CAS No. 81329-71-7. Pack Sizes: 5mg. Molecular Formula: C22H28N2O3, Molecular Weight: 368.47. US Biological Life Sciences. | Worldwide |
| Modified Alkyd | Modified Alkyd. Group: Polymers. |  |
| Modified defensin | Modified defensin is a synthetic construct peptide and has antibacterial activity. | |
| Modified Starches | Modified Starches. CAS No. 68412-35-1. Product ID: PE-0339. Category: Excipients. Product Keywords: Pharmaceutical Excipients; Excipients; Modified Starches; PE-0339; 68412-35-1; 68412-35-1. Standard: In-house standard. Grade: Pharmaceutical grade. | |
| Modified T7 RNA polymerase | A modified T7 RNA polymerase that orthogonally recognizes a non-natural promoter sequence: 5-TAATACCGGTCACTATA, where the underlined residues differ from wild-type. Group: Enzymes. Synonyms: CGG-R12-KIR. Enzyme Commission Number: EC 2.7.7.6. CAS No. 9014-24-8. Purity: > 98% (SDS-PAGE). Mole weight: 100.142 kDa. Storage: at -20 °C. Form: Liquid. CGG-R12-KIR; Non-Natural Promoter T7 Polymerase; modified T7 RNA polymerase; T7 RNA polymerase. Cat No: NATE-1698. |  |
| Modotuximab | Modotuximab (DS 1024) is an IgG1κ-type chimeric antibody targeting human EGFR protein. Modotuximab binds non-overlapping epitopes on domain III of EGFR, a domain that is intact in EGFRvIII. Modotuximab has antitumor activity in vivo [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: DS 1024. CAS No. 1310460-86-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99306. | |
| Moenomycin Complex | Moenomycin complex is a mixture of five major components: A, A12, C1, C3 and C4 isolated from several strains of Streptomyces in the 1960s. Moenomycins are high molecular weight phosphoglycolipids with potent antibiotic activity used in animal health. Moenomycins are the only antibiotic known to selectively inhibit the transglycosylation step catalyzed by penicillin-binding protein 1b. Group: Biochemicals. Alternative Names: Streptomyces A, A12, C1, C3 and C4. Grades: Highly Purified. CAS No. 11015-37-5. Pack Sizes: 5mg. Molecular Formula: C69H107N4O35P, Molecular Weight: ~1583.6. US Biological Life Sciences. | Worldwide |
| Moexiprilat-[d5] | Moexiprilat-[d5] is a deuterated isotope metabolite of moexipril, an inhibitor of angiotensin-converting enzyme (ACE). Synonyms: [3S-[2[R*(R*)],3R*]]-2-[2-[(1-Carboxy-3-(phenyl-d5)propyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid. Grade: > 95%. CAS No. 1356840-08-8. Molecular formula: C25H25N2O7D5. Mole weight: 475.56. | |
| Moexiprilat-d5 (2-[2-(1-Carboxy-3-phenyl-d5-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid) | Labeled analogue of Quinapril. Group: Biochemicals. Alternative Names: 2-[2-(1-Carboxy-3-phenyl-d5-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Moexiprilat Hydrate (2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid Hydrate) | Analogue of Quinapril. Group: Biochemicals. Alternative Names: 2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid Hydrate. Grades: Highly Purified. CAS No. 103775-14-0. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Moexipril Cyclohexyl Analogue Hydrochloride | An impurity of Moexipril. Group: Biochemicals. Alternative Names: (S)-2-{(S)-2-[(S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Moexipril-[d5] | Moexipril-[d5] is the labelled analogue of Moexipril, which is a potent orally active nonsulfhydryl angiotensin converting enzyme(ACE) inhibitor with antihypertensive activity. Synonyms: Moexipril D5; (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-(phenyl-d5)propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid. Grade: 95% by HPLC; 95% atom D. CAS No. 1356929-49-1. Molecular formula: C27H29D5N2O7. Mole weight: 503.6. | |
| Moexipril-d5 ((3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid, RS-10085-d5) | Angiotensin converting enzyme (ACE) inhibitor; dimethoxy analog of quinapril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid; RS-10085-d5. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Moexipril Diketopiperazine | An impurity of Moexipril. The degradation kinetics of Moexipril produced by organic solvents. Group: Biochemicals. Alternative Names: (αS,3S,11aS)-1,3,4,6,11,11a-Hexahydro-8,9-dimethoxy-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetic Acid Ethyl Ester; [3S-[2(R*),3α,11a β]]-1,3,4,6,11,11a-Hexahydro-8,9-dimethoxy-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetic Acid Ethyl Ester; PD 114009. Grades: Highly Purified. CAS No. 103733-51-3. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril hydrochloride | Moexipril hydrochloride (RS-10085) is an orally active inhibitor of angiotensin-converting enzyme ( ACE ), and becomes effective by being hydrolyzed to moexiprila (hydrochloride). Moexipril hydrochloride exhibits antihypertensive and neuroprotective effects [1] - [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RS-10085. CAS No. 82586-52-5. Pack Sizes: 10 mM * 1 mL; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0378A. | |
| Moexipril hydrochloride | Moexipril hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 82586-52-5. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Moexipril Hydrochloride ((3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride, CI-925, RS-10085-197, SPM-925, Fempress, Perdix, Univasc) | Angiotensin converting enzyme (ACE) inhibitor; dimethoxy analog of quinapril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride; CI-925; RS-10085-197; SPM-925; Fempress; Perdix; Univasc. Grades: Highly Purified. CAS No. 82586-52-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Methyl Benzyl Ester Maleate | Moexipril derivative. Group: Biochemicals. Alternative Names: [3S-[2-(S),3S]]-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-[[1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-3-isoquinolinecarboxylic Acid Benzyl Ester Maleate. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Methyl Ester Analog Hydrochloride Salt | An impurity of Moexipril. Group: Biochemicals. Alternative Names: [3S-[2-(S),3S]]-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-[[1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-3-isoquinolinecarboxylic Acid Hydrochloride. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound D | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound F | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound G | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril tert-Butyl Ester Maleic Acid Salt | An impurity of Moexipril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid 1,1-Dimethylethyl Ester; (2Z)-2-Butenedioate. Grades: Highly Purified. CAS No. 103733-40-0. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| MOF | MOF. Group: Carboxylic acid nitrogen-containing mixed mof ligand-multiple mixed ligand. Molecular formula: white powder. | |
| MOF&1,1',1'',1'''-ethene-1,1,2,2-tetrayltetrakis(4-methylbenzene) | MOF&1,1',1'',1'''-ethene-1,1,2,2-tetrayltetrakis(4-methylbenzene). Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,1':2',1''-Terphenyl, 4,4''-dibromo-3',4',5',6'-tetrakis(4-bromophenyl)- | MOF&1,1':2',1''-Terphenyl, 4,4''-dibromo-3',4',5',6'-tetrakis(4-bromophenyl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 20 mg. | |
| MOF&1,1',2,2'-tetrakis(4-bromophenyl)ethene | MOF&1,1',2,2'-tetrakis(4-bromophenyl)ethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&1,1,2-Triphenyl-2-(4- bromomethylphenyl)ethylene | MOF&1,1,2-Triphenyl-2-(4- bromomethylphenyl)ethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1, 1'-(5'-(4-acetylphenyl)-[1, 1':3', 1''-terphenyl]-4, 4''-diyl)diethanone | MOF&1, 1'-(5'-(4-acetylphenyl)-[1, 1':3', 1''-terphenyl]-4, 4''-diyl)diethanone. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 50 mg. | |
| MOF&[1, 1'-Binaphthalene]-2, 2'-diamine | MOF&[1, 1'-Binaphthalene]-2, 2'-diamine. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10mL. Product ID: 1-(2-aminonaphthalen-1-yl)naphthalen-2-amine. Molecular formula: 284.4g/mol. Mole weight: C20H16N2. InChI=1S / C20H16N2 / c21-17-11-9-13-5-1-3-7-15 (13) 19 (17) 20-16-8-4-2-6-14 (16) 10-12-18 (20) 22 / h1-12H, 21-22H2. DDAPSNKEOHDLKB-UHFFFAOYSA-N. | |
| MOF&[1,1-bis(4-N,N-dimethylphenyl)-2,2-bis(4-bromophenyl)]ethylene | MOF&[1,1-bis(4-N,N-dimethylphenyl)-2,2-bis(4-bromophenyl)]ethylene. Group: Organic-linker blocks-bi-substituted tpe. | |
| MOF&1,1-diphenyl-2,2-di(4-bromomethyl-phenyl)ethylene | MOF&1,1-diphenyl-2,2-di(4-bromomethyl-phenyl)ethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 20 mg. | |
| MOF&1,1-diphenyl-2,2-di(p-bromophenyl)ethylene | MOF&1,1-diphenyl-2,2-di(p-bromophenyl)ethylene. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: Customized service. | |
| MOF&1,2-Benzenedicarbonitrile, 4,5-diamino- | MOF&1,2-Benzenedicarbonitrile, 4,5-diamino-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 20 mg. | |
| MOF&1,2-Bis[4-(bromomethyl)phenyl]-1,2-diphenylethene | MOF&1,2-Bis[4-(bromomethyl)phenyl]-1,2-diphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. Product ID: 1-(bromomethyl)-4-[(E)-2-[4-(bromomethyl)phenyl]-1,2-diphenylethenyl]benzene. Molecular formula: 518.3g/mol. Mole weight: C28H22Br2. InChI=1S / C28H22Br2 / c29-19-21-11-15-25 (16-12-21) 27 (23-7-3-1-4-8-23) 28 (24-9-5-2-6-10-24) 26-17-13-22 (20-30) 14-18-26 / h1-18H, 19-20H2 / b28-27+. GHZTXESUSOBGAM-BYYHNAKLSA-N. | |
| MOF&1,2-Bis(4-bromophenyl)-1,2-diphenylethene | MOF&1,2-Bis(4-bromophenyl)-1,2-diphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. Product ID: 1-bromo-4-[(E)-2-(4-bromophenyl)-1,2-diphenylethenyl]benzene. Molecular formula: 490.2g/mol. Mole weight: C26H18Br2. InChI=1S/C26H18Br2/c27-23-15-11-21 (12-16-23)25 (19-7-3-1-4-8-19)26 (20-9-5-2-6-10-20)22-13-17-24 (28)18-14-22/h1-18H/b26-25+. BBSNJTOHVHUCRF-OCEACIFDSA-N. | |
| MOF&1,2-Bis(4-hydroxyphenyl)-1,2-diphenylethylene | MOF&1,2-Bis(4-hydroxyphenyl)-1,2-diphenylethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,2-di-[4-(aminomethyl)phenyl]-1,2-diphenylethylene | MOF&1,2-di-[4-(aminomethyl)phenyl]-1,2-diphenylethylene. Group: Organic-linker blocks-bi-substituted tpe. | |
| MOF&1,2-Di(4-carboxyphenyl)-1,2,2-triphenylethene | MOF&1,2-Di(4-carboxyphenyl)-1,2,2-triphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Carboxylic acid mof ligand-dicarboxylic acid mof ligand. Pack Sizes: 20 mg. | |
| MOF&[1,2-diphenyl-1,2-bis(4-cyanophenyl)ethylene | MOF&[1,2-diphenyl-1,2-bis(4-cyanophenyl)ethylene. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10mL. | |
| MOF&1,2-Ethanediamine, N,N-bis(2-pyridinylmethyl)- | MOF&1,2-Ethanediamine, N,N-bis(2-pyridinylmethyl)-. Group: Organic-linker blocks- other linker blocks. | |
| MOF&1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene | MOF&1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene. Uses: Composite materials, bio-labeling, optoelectronic devices, fluorescence materials etc. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 ml. | |
| MOF&1,3,2-Dioxaborolane, 2,2'-[(1,2-diphenyl-1,2-ethenediyl)di-4,1-phenylene]bis[4,4,5,5-tetramethyl- | MOF&1,3,2-Dioxaborolane, 2,2'-[(1,2-diphenyl-1,2-ethenediyl)di-4,1-phenylene]bis[4,4,5,5-tetramethyl-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,3,5-Triazine, 2,4,6-tris(3,5-dimethyl-1H-pyrazol-1-yl)- | MOF&1,3,5-Triazine, 2,4,6-tris(3,5-dimethyl-1H-pyrazol-1-yl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Nitrogen-containing mof ligand-ternary nitrogen-containing mof ligand. CAS No. 154403-27-7. Pack Sizes: 20 mg. Product ID: 2,4,6-tris(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine. Molecular formula: 363.4g/mol. Mole weight: C18H21N9. InChI=1S/C18H21N9/c1-10-7-13 (4)25 (22-10)16-19-17 (26-14 (5)8-11 (2)23-26)21-18 (20-16)27-15 (6)9-12 (3)24-27/h7-9H, 1-6H3. DGBHCVCPUCYWEM-UHFFFAOYSA-N. | |
| MOF&1,3,5-Tris(4-bromophenyl)benzene | MOF&1,3,5-Tris(4-bromophenyl)benzene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 10 mg. Product ID: 1,3,5-tris(4-bromophenyl)benzene. Molecular formula: 543.1g/mol. Mole weight: C24H15Br3. InChI=1S/C24H15Br3/c25-22-7-1-16 (2-8-22)19-13-20 (17-3-9-23 (26)10-4-17)15-21 (14-19)18-5-11-24 (27)12-6-18/h1-15H. HJQRITCAXSBOPC-UHFFFAOYSA-N. | |
| MOF&1,3,6,8-Tetrabromopyrene | MOF&1,3,6,8-Tetrabromopyrene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 10 mg. Product ID: 1,3,6,8-tetrabromopyrene. Molecular formula: 517.8g/mol. Mole weight: C16H6Br4. InChI=1S/C16H6Br4/c17-11-5-13 (19)9-3-4-10-14 (20)6-12 (18)8-2-1-7 (11)15 (9)16 (8)10/h1-6H. ZKBKRTZIYOKNRG-UHFFFAOYSA-N. | |
| MOF&1, 3- Benzenedicarboxylic acid, 5- borono- | MOF&1, 3- Benzenedicarboxylic acid, 5- borono-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- isophthalate. Pack Sizes: 20 mg. | |
| MOF&1-(4-Aminophenyl)-1,2,2-triphenylethene | MOF&1-(4-Aminophenyl)-1,2,2-triphenylethene. Uses: Na. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 100 mg. | |
Our database is helping our users find suppliers everyday.
